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ARTICLE
Nucleotide resolution mapping of inﬂuenza A virus
nucleoprotein-RNA interactions reveals RNA
features required for replication
Graham D. Williams1,2, Dana Townsend2, Kristine M. Wylie3,4, Preston J. Kim5, Gaya K. Amarasinghe5,6,
Sebla B. Kutluay2 & Adrianus C.M. Boon1,2,5
Inﬂuenza A virus nucleoprotein (NP) association with viral RNA (vRNA) is essential for
packaging, but the pattern of NP binding to vRNA is unclear. Here we applied photo-
activatable ribonucleoside enhanced cross-linking and immunoprecipitation (PAR-CLIP) to
assess the native-state of NP–vRNA interactions in infected human cells. NP binds short
fragments of RNA (~12 nucleotides) non-uniformly and without apparent sequence speciﬁ-
city. Moreover, NP binding is reduced at speciﬁc locations within the viral genome, including
regions previously identiﬁed as required for viral genome segment packaging. Synonymous
mutations designed to alter the predicted RNA structures in these low-NP-binding regions
impact genome packaging and result in virus attenuation, whereas control mutations or
mutagenesis of NP-bound regions have no effect. Finally, we demonstrate that the sequence
conservation of low-NP-binding regions is required in multiple genome segments for pro-
pagation of diverse mammalian and avian IAV in host cells.
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Inﬂuenza A virus (IAV) possesses a segmented, negative-senseRNA genome that is bound by the viral nucleoprotein (NP)throughout replication. Recent cryo-electron microscopy stu-
dies of the IAV ribonucleoprotein complex (vRNP) provide evi-
dence for a NP–RNA complex structure with a corkscrew-like
morphology and the tripartite polymerase complex at one end
and a loop at the other end. However, current models conﬂict
with each other and yield no information about RNA con-
formation, binding, or NP–RNA association1,2. NP is thought to
coat viral RNA (vRNA) uniformly in cells and virus particles;
however. uniform coating likely would preclude the possibility for
RNA structure formation in RNPs. Numerous virus families
utilize structured RNA elements for speciﬁc biological processes
throughout infection, including genome packaging3,4. For
example, viral RNA elements are required for efﬁcient replication,
mRNA splicing, and genome packaging of IAV5–7. Structure
formation has been demonstrated with in vitro folded IAV vRNA
and engineered genome segments, but the structural constraints
imposed by nucleoprotein on vRNA generated during infection is
not known8,9. Elucidation of the physiological interaction
between NP and viral genomic RNA may provide novel insights
into how IAV is capable of coordinating its lifecycle. Thus, we set
out to determine the in vivo landscape of NP–vRNA interactions.
Infection and complete replication of IAV requires delivery of
all eight genome segments into a recipient cell. All IAV segments
require packaging signals derived from the termini on each seg-
ment10,11. Interaction between vRNAs has been demonstrated
in vitro and disruption of packaging signals or interacting seg-
ment regions attenuated virus replication at the stage of genome
packaging12–14. In many cases, mutation of a single segment leads
to a signiﬁcant decrease in the packaging efﬁciency of other
segments5,15. Additionally, viral particles largely package only one
copy of each genome segment16–18. Together, these results sug-
gest that genome segments function as a multipartite, coopera-
tively packaged entity, possibly potentiated by segment–segment
interactions, rather than a stochastically generated particle19,20.
In this study, we set out to determine how IAV NP interacts
with vRNA during infection in cells. We show that the NP of IAV
binds the vRNA non-uniformly and that regions of low-NP
binding are enriched for predicted RNA secondary structures.
Synonymous mutations designed to destabilize the predicted
RNA structure attenuate IAV replication, whereas synonymous
mutations that maintain the predicted RNA structure or muta-
tions in NP-bound RNA regions have no effect on virus repli-
cation in vitro or in vivo. Viral attenuation is associated with an
increase in defective virus production, suggesting that low-NP-
binding regions and the predicted RNA structures are required
for viral genome packaging.
Results
Nucleotide resolution mapping of NP–vRNA interactions.
Photoactivatable ribonucleoside enhanced cross-linking and
immunoprecipitation (PAR-CLIP) coupled to next-generation
sequencing was used to resolve the interaction between the
negative-sense RNA genome of IAV and NP during infection of
human 293T cells21. We infected human cells with WT-PR8 virus
for 16 h in the presence of 4-thiouridine (4-SU) to enhance cross-
linking of NP–RNA complexes and then generated Illumina
1 × 50 sequencing libraries of the NP-bound RNA (Fig. 1a). The
impact of 4-SU on viral replication was assessed in 293T cells.
WT-PR8 replicated to equivalent titers 12, 18, and 24 h post-
infection (hpi) in mock- or 4-SU-treated (100 μM) cells (Fig. 1b).
Additionally, NP localization after 4-SU treatment was assessed
by confocal microscopy at 16 hpi, and no alteration was observed
at this time point (Fig. 1b). These results suggest that 4-SU
treatment does not substantially impact IAV nucleoprotein pro-
duction or replication in human cells.
To determine the sensitivity and speciﬁcity of the PAR-CLIP
assay, we performed Western blotting analysis for IAV NP and
cellular ß-actin on input lysate and immunoprecipitated proteins
(Fig. 1c, bottom). Compared to immunoprecipitations performed
without antibody or a control anti-HA antibody, immunopreci-
pitation with a monoclonal antibody (MAb) against IAV NP
produced a speciﬁc band. UV-exposure of infected cells in the
presence of 4-SU enabled greater recovery of NP–RNA complexes
(Fig. 1c, top). The protein purity in the immunoprecipitate was
veriﬁed by silver stain or Western blotting with an anti-IAV
polyclonal serum (Supplementary Fig. 1a, b).
Inﬂuenza A nucleoprotein binds viral RNA non-uniformly.
PAR-CLIP identiﬁed both human and virus-derived RNAs that
interacted with NP. The procedure enriched for IAV RNA
sequences relative to RNA-seq libraries (Fig. 1d), and the majority
of the viral RNA sequences were derived from the negative-strand
vRNA (Supplementary Fig. 2). The average length of the NP-
bound vRNA was 12 nucleotides (range 11–14, Fig. 1e).
We then compared PAR-CLIP and RNA-seq libraries to
identify contiguous regions of vRNA that are signiﬁcantly under-
and overrepresented among the NP-bound RNAs. Using the
criteria of >3-fold difference, Q< 0.01, and ≥ 18 nucleotides long,
we identiﬁed 24 regions in the viral genome that were low in NP
binding relative to RNA-seq and 18 regions that met two of these
three criteria that we did not investigate further (Supplementary
Fig. 3, Supplementary Table 1). Moreover, four high-NP-binding
regions where vRNA was overrepresented in PAR-CLIP libraries
relative to the control RNA-seq sets were identiﬁed (Supplemen-
tary Table 1). The low-NP-binding regions together represent
~10% of the viral genome and do not differ in base composition
from the remainder of the genome (Fig. 1f). Analysis of the
nucleotide sequences in low-NP-binding regions revealed that
RNA secondary structures are predicted to form in the absence of
NP binding in some of these regions (Supplementary Table 1)5,7.
Thus, NP binding might be affected by local secondary structures
in the genome of IAV.
Segment 5 low-NP-binding regions are important for IAV. To
assess the signiﬁcance of the NP-bound or underrepresented
vRNA regions, we selected six regions in segment 5 that have
variable NP-binding proﬁles (Fig. 2a and Table 1). The lack of
alternative reading frames and splicing of segment 5 mRNA made
this segment highly suitable for extensive characterization of the
signiﬁcance of the low-NP-binding regions on IAV replication.
Of the six regions, two were underrepresented (low-NP binding)
in PAR-CLIP data sets (NP22–68 and NP1410–1495). The
NP1410–1495 region contains a previously hypothesized vRNA
pseudoknot5. Additional regions of NP intermediate binding
(NP145–175, NP456–490, NP584–608, and NP1058–1081) were also
included in the following studies. Computational prediction of
RNA structures using RNAfold in low-NP-binding regions gui-
ded further mutational analysis, and these regions were muta-
genized to either disrupt (NP22–68:A and NP1410–1495) or maintain
(NP22–68:B) the predicted secondary and tertiary structure for-
mation (Supplementary Fig. 4). Mutant viruses bearing
2–7 synonymous structural nucleotide changes in these regions
were generated and assessed for ability to replicate in vitro and
in vivo.
WT and mutant viruses were subjected to a focus-forming
assay in MDCK cells to determine replication competence in vitro
(Fig. 2b). Mutations disrupting the segment 5 vRNA pseudoknot
(NP1410-1495) formation and destabilizing a predicted stem-loop
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structure (NP22–68:A) in the 3′ region of the vRNA segment
resulted in reduction of focus area, as a measure of multi-cycle
replication and spread (Fig. 2b). Conversely, mutation of
intermediate NP-bound vRNA regions did not alter the focus
area. Synonymous mutations in NP22–68 designed to maintain the
predicted secondary structure (NP22–68:B), also did not affect
focus size (Fig. 2b). Multi-cycle replication assays in MDCK cells
of select mutant viruses conﬁrmed these results (Fig. 2c). Finally,
mice were inoculated with 103 TCID50 of each virus, and the
presence of infectious virus in the lung was assessed 48 h later.
WT-PR8 replicated to high titers at this time point whereas
destabilizing mutations in low-NP-binding regions resulted in
attenuation (Fig. 2d). Synonymous structural mutations in NP-
bound regions had no effect on virus infection in vivo (Fig. 2d).
These results collectively suggest that structural features of the
low-NP-binding regions are important for IAV replication.
To determine the cause of attenuated replication of low-NP-
binding mutant viruses, we evaluated effects on speciﬁc stages in
the IAV lifecycle. All viruses displayed similar cytoplasmic
distribution of NP 8 hpi in MDCK cells when assessed by
indirect immunoﬂuorescence and confocal microscopy (Fig. 3a).
The ability of the NP proteins from mutant viruses to facilitate
the transcription and replication of a ﬁreﬂy luciferase reporter
genome segment by the tripartite IAV polymerase complex was
tested in human cells; all viruses displayed equivalent reporter
activity (Fig. 3b). Similarly, infection of MDCK cells with all
viruses generated equivalent amounts of viral antigen (NP) 8 hpi



























































































































Fig. 1 Development of PAR-CLIP for IAV NP. a Schematic for IAV NP PAR-CLIP assay. b Effects of 4-SU on IAV replication. Viral replication (MOI= 0.1) in
the presence or absence of 4-SU (100 μM) was assessed by performing a growth curve at the indicated times in 293T cells and titered by TCID50 assay in
MDCK cells (bottom). Results are the average + s.e.m. of two experiments. NP localization was assessed following treatment and infection of 293T cells by
confocal microscopy (top). Immunoﬂuorescence staining for NP (green) was assessed in the presence or absence of 4-SU and counterstained with DAPI to
identify cellular nuclei (blue). Scale bar indicates 25 µm. c PAR-CLIP was conducted on 293T cells infected with WT-PR8 in the absence (lanes 1 and 2) or
presence of a monoclonal antibody against to IAV NP (lanes 3–6) or viral hemagglutinin protein (HA) (lanes 7–8). The effect of UV cross-linking on
binding of RNA to the viral NP is shown in lanes 3–4 (no UV) and lanes 5–6 (with UV). Radioactivity (32P) is visualized by autoradiograph and the presence
or absence of NP and cellular ß-actin was done by western blot. The input sample and eluate are loaded in the uneven and even lanes, respectively. The
results are representative of four independent experiments. Original western blots and autoradiograph are shown in Supplementary Fig. 7. d Proportion of
PAR-CLIP or RNA-seq derived reads mapping to human or IAV genomes (**P< 0.01 by one-way ANOVA with multiple comparisons correction
(Kruskal–Wallis test), n= 4). e Length of negative-sense viral RNA (vRNA) aligning reads was determined using FastX Toolkit and the number of reads of a
certain length is plotted as a proportion of total vRNA mapping reads. Mean (black line)± s.e.m. (blue shading) of 4 experiments. f Nucleotide composition
of low-NP-binding regions and IAV genome (displayed as average + s.e.m. base composition of all eight gene-segments). No signiﬁcant differences were
detected between groups (one-way ANOVA with multiple comparisons correction (Kruskal–Wallis test))
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synonymous mutations introduced within NP segment did not
alter NP expression or its activity by all measurable outcomes.
We next assessed the virus particle to infectious unit ratio of
WT and mutant PR8 viruses to evaluate potential defects in viral
genome packaging. The infectious titer (TCID50 ml−1) of
NP1410–1495 and NP22–68:A mutant viruses was signiﬁcantly lower
(P< 0.05) compared to all other viruses when normalized to HA-
units, indicating a greater production of non-infectious particles
(Fig. 3d). The ability of WT and mutant viruses to package all
eight genome segments was assessed using a population level
measure of relative vRNA segment abundance in puriﬁed viral
particles22. RNA from WT and mutant IAVs was subjected to
RT-qPCR and the abundance of segments was normalized to
segment 7 (Fig. 3e). Mutation of either the predicted pseudoknot
(NP1410–1495) or stem-loop structure (NP22–68:A) resulted in
aberrant genome constellation stoichiometry. Consistent with
the viral replication assays, mutation of intermediate NP-bound
regions or mutations designed to maintain the predicted 3′ stem-
loop structure (NP22–68:B) result in unaltered ratios of genome
segments in all but one segment-speciﬁc instance (Fig. 3e and
Supplementary Fig. 5a). These results suggest that RNA structure-
destabilizing mutations, in regions of vRNA poorly bound by NP,
impact replication at the stage of coordinated genome packaging.
Finally, we determined the co-expression of NP and matrix (M)
proteins in singly infected cells (Fig. 3f, multiplicity of infection
(MOI) of 0.05)23. In agreement with the RT-qPCR data,
suggesting a packaging defect, a lower percentage of NP1410–1495
and NP22–68:A mutant virus-infected cells co-expressed both
proteins compared to cells infected with WT or other mutant
viruses. Notably, high MOI infection with multiple defective
particles simultaneously infecting the same cell is able to
overcome this defect (Supplementary Fig. 5b).
Additional low-NP-binding regions impact IAV replication.
Low-NP-binding regions in segments 1, 2, and 8 also were
evaluated for their contribution to viral replication by mutagen-
esis designed to disrupt predicted secondary and tertiary RNA
structures (Fig. 4a–c, Supplementary Table 1 and Supplementary
Data 1). Nucleotide substitutions that alter the predicted RNA
secondary structure but have no impact on the protein,
i.e., synonymous structural mutations, in segment 1
(PB21823–1944:A-C), segment 2 (PB1497-561:A) and segment 8
(NS23–86:A) reduced the focus area of mutant viruses in MDCK
cells (Fig. 4d–f). Control mutations, designed to maintain the
predicted vRNA structure in the low-NP-binding regions on
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Fig. 2 Manipulation of vRNA in low-NP-binding regions that disrupts predicted RNA structure attenuates virus replication. a Normalized coverage± s.e.m.
was determined for each nucleotide in the PAR-CLIP (red symbols) and RNA-seq (black symbols) libraries (n= 4 each). Six regions of interest (ROI) in
segment 5 (NP) are highlighted, including two low-NP-binding regions (NP1410–1495 and NP22–68) and four intermediate NP-binding regions (NP145–175,
NP456–490, NP584–608, and NP1058–1081). Each ROI is indicated with a colored bar. b Focus area of WT-PR8 and NP mutant IAV. MDCK cells were infected
with serial dilutions of the indicated viruses and overlayed with infection media (M0.1B) containing 1% agarose and TPCK-trypsin. Seventy-two hours later
cells were ﬁxed, permeabilized, and stained for viral antigen (NP). Focus diameter was determined and normalized to WT-PR8 per experiment. Results are
the average + s.e.m. of 3–5 experiments per virus (>60 foci each). c MDCK cells were infected with MOI= 0.001 of the indicated viruses and culture
supernatant was collected at indicated time points then titered on MDCK cells. Results are the average± s.e.m. TCID50 ml−1 of two experiments performed
in duplicate. d C57BL/6J mice were inoculated with 103 TCID50 of the indicated viruses in 30 µL. Lungs were collected, homogenized, and titered on MDCK
cells. Each dot is a single mouse and the line is the median. Dotted line in c, d represents the limit of detection. (***P< 0.005; **P< 0.01; n.s. not signiﬁcant
by one-way ANOVA with multiple comparisons correction (Kruskal–Wallis test))
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size (Fig. 4e, f). Similar to the attenuation of structurally disrupted
segment 5 viruses, the PB21823–1944:A-B, PB1497–561:A or NS23–86:A
mutant viruses generated fewer TCID50 particles per HA-unit,
while the control mutations (PB1497–561:B or NS23–86:B) did not
(Fig. 4g–i). The PB21823–1944 mutant that showed the least
attenuation in the focus-forming assay, PB21823–1944:C, had no
discernable difference in TCID50 per HA-unit. Segment 1 (PB2)
and 2 (PB1) mutants did not display altered reporter activity
(Supplementary Fig. 6a). In contrast to the impact of synonymous
mutations in low-NP-binding regions, mutations in NP-bound
regions in segment 1 (PB2350–375 and PB22213–2239) and segment 2
(PB11828–1858 and PB12032–2058) did not alter focus size or TCID50
per HA-unit (Fig. 4d, e, g, h, and Supplementary Fig. 5a). Speciﬁc
manipulation of segment 8 vRNA sequence (NS23–86:A) resulted
in decreased packaging of segments 3, 4, 5, and 7 relative to
segment 1 (Fig. 4j). Assessment of vRNA abundance in virus
particles revealed that segment 2 (PB1497–561:A) mutant viruses
packaged reduced levels of segment 6 vRNA (NA) (Fig. 4j). The
PB21823–1944:A virus did not show altered segment abundance
(Fig. 4k and Supplementary Fig. 6b). Finally, virus replication of
the PB21823–1944:A, PB1497–561:A and NS23–86:A mutant viruses in
mice was diminished 48 hpi compared to WT-PR8 (Fig. 4k).
Together, these data suggest that vRNA sequences that are low in
NP binding help to coordinate packaging of a full complement of
eight vRNA segments and changes to the predicted RNA struc-
tures in these regions results in virus attenuation. To demonstrate
that synonymous structural mutations affect the stability of the
predicted RNA structure, we performed RNA thermal stability
assays using RNA oligomers corresponding to the low-NP-
binding region PB1497–56124. The thermal proﬁle of the RNA
containing the predicted structure-destabilizing mutations
(PB1497–561:A) was different from that of the WT RNA oligomer
and the RNA containing synonymous mutations that maintained
the RNA structure (PB1497–561:B) (Supplementary Fig. 4d).
Moreover, the thermal melt proﬁle for the destabilizing mutations
(PB1497–561:A) indicated a lower thermal stability. In contrast, the
thermal proﬁle of the PB1497–561:B RNA was similar to that of WT
RNA. Combined these data show that stable RNA structures are
required for IAV replication and genome packaging.
Mutation of low-NP-binding regions attenuates diverse IAV.
We evaluated the contribution of two low-NP-binding regions
(PB21823–1944 and NP1410–1495), identiﬁed in WT-PR8, to the
replication of a North American avian IAV (A/shorebird/Dela-
ware/22/2006 (IAV-H7N3)) and the 2009 pandemic H1N1 IAV
(A/California/04/2009 (IAV-pH1N1)). The PB2 and NP gene-
segment of IAV-PR8 and IAV-H7N3 are divergent and repre-
sentative of mammalian and avian viruses, respectively (Fig. 5a, b,
Supplementary Fig. 4). The NP gene-segment of IAV-pH1N1 is
closely related to IAV-PR8 (Fig. 5a, Supplementary Fig. 4), while
the PB2 gene-segment is more closely related to avian viruses
(Fig. 5b, Supplementary Fig. 4). Isogenic IAV-H7N3 and IAV-
pH1N1 viruses, bearing synonymous mutations in the
NP1410–1495 or PB21823–1944 regions, designed to disrupt the pre-
dicted local RNA structure, were evaluated for virus replication
in vitro. Synonymous mutations designed to impact the predicted
RNA secondary structure in these regions of IAV-H7N3 and
IAV-pH1N1 attenuated viral replication, as measured by focus
area (Fig. 5c, e). All mutant viruses displayed decreased TCID50
per HA-unit (Fig. 5d, f). These results indicate that the RNA
features, identiﬁed by PAR-CLIP in IAV-PR8, are important in
genome packaging of diverse avian and human strains of IAV.
Discussion
We have identiﬁed the interaction landscape of IAV NP with viral
RNA in the context of infected cells. Our ﬁndings indicate that
binding of NP to viral RNA is restricted to an average of 12
nucleotides and the distance between two cross-linking sites is 25
nucleotides. These estimates agree with molecular models of
NP–RNA interactions and the NP-binding footprint of a related
orthomyxovirus1,20,25,26. Within this model, NP is excluded from
consistent interaction with speciﬁc regions of vRNA and allows
trans-interactions with either other genome segment vRNA or
host and virus factors. The interaction between NP and the viral
RNA was non-uniform and characterized by regions that were
Table 1 Disruption of predicted RNA structures attenuates IAV
Virus NP-bound MFE Effect of mutations Effects on virus
Focus size Lung titer Genome packaging
TCID50:HA ratio Segment packaging
NP22–68:A -- −8.7 ↓–ΔG ↓↓ ↓ ↓↓ ↓↓
NP22–68:B -- −8.7 No effect = = = =
NP145–175 = −8.0 ↓–ΔG = = = =
NP456–490 = −3.2 No effect = = = =
NP584–608 = −0.0 No effect = = = =
NP1058–1081 = −0.0 No effect = = = =
NP1410–1495 -- −19.8 Modiﬁed Pseudoknot ↓↓ ↓↓ ↓↓ ↓↓
PB2350–375 = −0.0 No effect = N.D. = =
PB21823–1944:A -- −33.0 Modiﬁed Pseudoknot ↓ ↓↓ ↓↓ =
PB21823–1944:B -- −33.0 Modiﬁed Pseudoknot ↓ N.D. ↓ =
PB21823–1944:C -- −33.0 Modiﬁed Pseudoknot ↓ N.D. = =
PB22213–2239 = −0.0 No effect = N.D. = =
PB1497–561:A -- −12.9 ↓–ΔG ↓ ↓ ↓↓ ↓↓
PB1497–561:B -- −12.9 No effect = N.D. = =
PB11828–1858 = −3.8 No effect = N.D. = =
PB12032–2058 = −2.2 No effect = N.D. = =
NS23–86:A -- −10.0 Modiﬁed Pseudoknot ↓↓ ↓ ↓↓ ↓↓
NS23–86:B -- −10.0 No effect = N.D. = =
For NP-binding, the following categories were considered: --, signiﬁcantly lower than WT-PR8; =, equal to WT-PR8; ++, greater than WT-PR8. The regional stability was determined in WT-PR8 and
mutant virus using Vienna RNAfold. All calculations were performed using the default settings without imposing structural constraints. Pseudoknot formation potential was determined using vsFold5 and
default settings. Results for focus area, lung titer, TCID50 ml−1:HA ratio, relative segment packaging are summarized from previous ﬁgures (=, equivalent to WT-PR8; ↓, P< 0.05; ↓↓, P < 0.01)
MFE minimum free energy (expressed as ΔG), N.D. not determined
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consistently low or high in NP binding. These results are in
agreement with recent ﬁndings from Lee et al.27. About half of the
low-NP regions are predicted to form secondary and tertiary
RNA structures, based on computational analysis, and mutations
designed to alter the stability of these predicted RNA structures
resulted in attenuated virus infection (summarized in Table 1).
The presence of RNA structures in RNP complexes may explain
the pleomorphic nature of RNPs28. Several, mostly shorter low-
NP-binding regions were not predicted to form stable structures.
These regions may represent a portion of a larger but less stable
structure or have a different yet unknown function during IAV
replication. At present, the function of high-NP-binding vRNA
regions is unknown. These regions may have a role in inter-
segment NP-based interactions or be regions of high-NP density,
enabled by position along the vRNP.
We examined NP–vRNA interactions at a late time point when
a majority of viral RNA is distributed throughout the cytoplasm
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the great majority of PAR-CLIP reads were obtained from
negative-sense vRNAs.
We found many low-NP-binding RNA regions that overlap
with previously predicted packaging and bundling signals near
segment termini (NP22–68, NP1410–1495, and NS23–88)5,30. How-
ever, additional low-NP-binding regions were identiﬁed
throughout the segment body and outside of traditional packa-
ging signals11,22,31. Our ﬁndings agree with studies assessing
structure-guided mutagenesis of hypothetical vRNA structures
(segment 7) or biochemical analyses of vRNA (segment 8) that
largely overlap with low-NP-binding regions assessed here7,32.
Additionally, we identiﬁed speciﬁc nucleotides required for co-
packaging of segment 2 (PB1) and segment 6 (NA), in a region
recently implicated in directing reassortment outcomes and co-
segregation of these segments in vitro33,34. Therefore, NP PAR-
CLIP allowed us to directly identify potentially functional RNA
regions in IAV genomes required for coordinated genome
packaging.
As predicted RNA structures in some low-NP-binding regions
are important for genome packaging, it suggests a requirement
for inter-segment RNA interactions. Speciﬁc RNA interactions
between genome segments have been demonstrated in vitro and
ablation of these interactions lead to aberrant genome packaging;
an outcome reversed by introduction of compensatory mutations
in the interacting segment12. Many of the mutations that alter
genome assembly also lead to an increase in number of defective
viral particles30. The formation and nature of vRNA structures is
likely contingent on the sequence composition and physical
position of the nucleotides within a RNP complex. Additionally,
manipulation of NP-bound regions, which may be unable to
make inter-segment contacts due to NP-induced structural con-
straints on vRNA, did not impact virus replication. The presence
of highly NP-bound vRNA regions may represent genomic
regions that are spatially or structurally organized in a manner
that allows improved protein binding, though we have not for-
mally tested this hypothesis within this study.
IAVs can reassort and generate novel and potential pandemic
strains. We tested if the regions identiﬁed in IAV-PR8 were
required for replication of a divergent H7N3 virus. Synonymous
changes designed to disrupt the predicted RNA structure in the
same vRNA regions of two separate segments in both IAV-H7N3
and IAV-pH1N1 were attenuating and suggest conservations of
these structural elements. Future examination of NP-binding of
viral RNA in diverse strains of IAV is likely to identify over-
lapping and distinct high and low-NP-binding regions. These
RNA features may be required for all viruses as coordinating
packaging elements, but additional regions act as strain or
lineage-speciﬁc packaging enhancers. Further, these strain or
lineage-speciﬁc RNA features, required for genome packaging,
may act as potential determinants of reassortment outcomes.
Prior experimental systems demonstrated that co-segregation of
genome segments occurs during natural reassortment as well as
lab-adaptation of virus strains to create new vaccines34,35. Finally,
attenuation of genome packaging through silent, structural
mutations has the potential to accelerate live attenuated vaccine
production using native genome constellations to allow vaccina-
tion with all protein epitopes of a novel pandemic virus, without
the need for master donor strains.
Methods
Cells. Madin–Darby Canine Kidney (MDCK) cells were maintained in minimal
essential medium (MEM) with 5% fetal bovine serum (FBS, Biowest), MEM-
vitamins (Gibco), L-glutamine (Gibco), and penicillin–streptomycin (Gibco).
Human embryonic kidney cells (293-T) were maintained in Opti-MEM (Life
Technologies) with 10% FBS, L-glutamine, and penicillin–streptomycin. MDCK
and 293T cells were a kind gift from Dr. Richard Webby at St. Jude Children’s
Research Hospital.
Viruses. Eight bidirectional pHW2000 plasmids containing cDNA for A/Puerto
Rico/08/1934 (H1N1), A/California/04/2009 (H1N1), or A/shorebird/Delaware/22/
2006 (H7N3) were previously described35. Viruses were generated by transfection
of all eight plasmids into co-cultures of 293T and MDCK cells (1 μg per plasmid)
with polyethylenimine (8 μg total). Wild-type (herein IAV-PR8 (WT-PR8), IAV-
pH1N1 (WT-pH1N1) or IAV-H7N3 (WT-H7N3) and mutant viruses were gen-
erated in the same manner with the exception of substituting individual plasmids
harboring mutagenized DNA for the single indicated wild-type plasmid. The next
day, the transfection mixture was removed and replaced with Opti-MEM con-
taining MEM-vitamins, L-glutamine and penicillin–streptomycin. Forty-eight
hours post-transfection, an additional 1 ml of the same media containing 1 μg ml−1
TPCK-Trypsin (Worthington) was added to the co-culture. Seventy-two hours
after addition of TPCK-Trypsin, culture supernatant was collected and clariﬁed by
centrifugation (5 min, 350 × g). Viral stocks were generated by infection of MDCK
cells in a T75 ﬂask. Cells were washed once with PBS, and 200 μl of transfection
supernatant was mixed with 25 ml of infection media (M0.1B) composed of MEM
containing vitamins, L-glutamine, penicillin–streptomycin, 0.1% Bovine Serum
Albumin (Gibco) and 1 μg ml−1 TPCK-Trypsin for 48 h. Stocks were aliquoted and
stored at −80 °C until use, and all studies were conducted with passage 1 stocks
following veriﬁcation of mutant sequence identity. All viruses were generated at
least twice independently. Sequences for primers utilized during mutagenesis of
IAV plasmids are available in Supplementary Table 2.
IAV nucleoprotein PAR-CLIP and RNA-seq library generation. To identify
interactions between viral RNA and IAV nucleoprotein, we adapted the protocol
for PAR-CLIP21 coupled to next-generation sequencing to discern nucleotide
resolution maps of protein–RNA interaction across the IAV genome. Conﬂuent
293-T cells were infected at an MOI of 1 for 16 h in the presence of 100 μM 4-
thiouridine (4-SU) and then cross-linked with ultraviolet light (310 nM, 500,000 μJ
total energy, Boekel Scientiﬁc UV Crosslinker AH (115 V)). PAR-CLIP was per-
formed essentially as described before21 with the exception of antibodies used to
immunoprecipitate NP–RNA complexes: monoclonal antibodies HB65 (ATCC) or
MAb8258 (EMD Millipore). On-bead Calf Intestinal Alkaline Phosphatase (CIP,
NEB) treatment was used to dephosphorylate RNA ends followed by 5′ end-
labeling with 32P catalyzed by T4 Polynucleotide Kinase (PNK, NEB). Brieﬂy,
protein–RNA complexes were separated on 4–12% SDS-PAGE gels and transferred
to nitrocellulose membranes. 32P-labeled RNA was identiﬁed by autoradiography,
excised, and extracted following proteinase K (New England Biolabs (NEB))
digestion. To account for potential bias introduced during adaptor ligation and
sequencing, we also generated RNA-seq libraries using RNA extracted from
Fig. 3 Attenuating mutations in segment 5 impact coordinated genome packaging. a Confocal microscopy images depicting the localization of
nucleoprotein (NP) 8 h post infection (hpi). MDCK cells were infected with the indicated virus (white text), and NP was identiﬁed using the MAb HB65 and
Alexa-488-conjugated goat-anti-mouse secondary antibody by immunoﬂuorescence. Cell nuclei are stained with DAPI. Panels depict the merged image of
DAPI and NP staining. Fields are representative of two independent experiments. Scale bar represents 25 µm. b Dual-luciferase reporter assay to assess
viral transcription and genome replication, each combination of plasmids was assessed 3–5 times with corresponding the WT-PR8 combination. (n.s., not
signiﬁcant by one-way ANOVA with multiple comparisons correction (Kruskal–Wallis)). c Mean ﬂuorescence intensity (MFI) of NP in virally infected
MDCK cells (MOI= 0.05, experiments were performed twice in duplicate) as revealed by ﬂow cytometry. (n.s., not signiﬁcant by one-way ANOVA with
multiple comparisons correction (Kruskal–Wallis)). d Viral titer (TCID50 ml−1) of 4 HA-units of WT-PR8 and mutant viruses. Results are the average + s.e.
m. of three viral titrations and two HA assays per infectious virus titration. (*P< 0.05; n.s., not signiﬁcant by unpaired t test). e Relative abundance of
genome segments in puriﬁed WT or mutant viruses. All segments were compared to segment 7 (M) vRNA and normalized to the average of WT-PR8
values using the 2-ddCt method22. Bars represent the mean of 3–6 independent virus preparations + s.e.m. (*P< 0.05; n.s., not signiﬁcant by one-way
ANOVA with multiple comparisons correction (Kruskal–Wallis)) f Proportion of infected cells co-expressing of matrix (M) and NP proteins in singly
infected MDCK cells (MOI= 0.05) 16 hpi as revealed by ﬂow cytometry. The average percentage of co-expression was calculated from two experiments
performed in duplicate. (n.s., not signiﬁcant by one-way ANOVA with multiple comparisons correction (Kruskal–Wallis))
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uncross-linked cell lysates of inﬂuenza infected 293T cells from which RNA was
isolated by TRIzol (Invitrogen) extraction, then 10 μg RNA was fragmented by
Mg2+ at 95 °C for 12 min (NEB, Magnesium RNA Fragmentation Module). 32P-
labeling of this RNA was performed in solution with T4 PNK (NEB), and size-
selection of 10–100 nt fragments by Urea-Page (15%) was performed. In both cases,
total RNA was precipitated with ethanol, and used to prepare Illumina sequencing
libraries. 3′-OH RNA previously prepared by CIP treatment was ligated to a 3′
adaptor using T4 RNA Ligase 2, truncated K227Q (NEB), according to manu-
facturer’s instructions. The 5′ adaptor sequence contains NNN-degenerate
nucleotides in addition to a sequence used for demultiplexing to facilitate
collapsing of redundantly generated PCR products and ascertain the frequency of
individual NP–RNA interaction events. This adaptor was ligated to the 5′-end of
RNA using T4 RNA Ligase 1 (NEB). Following isolation of adaptor ligated and
radiolabeled RNA, all subsequent library generation steps were identical. Inde-
pendent PAR-CLIP or RNA-seq libraries were pooled and cDNA synthesized using
a primer complementary to the 3′ adaptor (SuperScript III, Invitrogen). Libraries
were ampliﬁed by PCR for 9–15 cycles using Phusion DNA polymerase (Phusion
HF Mastermix, Thermo) and primers annealing to the 5′ and 3′ termini of the
DNA that enable ﬂow-cell binding. Size selection of libraries was conducted by
extraction of amplicons from 6% urea gel electrophoresis, and then libraries were
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Fig. 4 Synonymous structural mutations in low-NP-binding regions in Segments 1, 2, and 8 attenuated virus replication and genome packaging. a–c
Segment 1 (a, blue line), 2 (b, red line), and 8 (c, green line) low-NP-binding regions deﬁned by PAR-CLIP analysis. Normalized coverage± s.e.m. was
determined for each nucleotide in the PAR-CLIP (blue, red or green symbols) and RNA-seq (black symbols) libraries (n= 4 each). d–f Relative focus area of
WT-PR8 and segment 1, 2, and 8 mutant viruses. Results are the average focus area + s.e.m. of 3 experiments per virus (>60 foci each). Statistical
signiﬁcance was determined by one-way ANOVA with a multiple comparisons correction (Kruskal–Wallis test). **P< 0.01; *P< 0.05. g–i Viral titer
(TCID50 ml−1) of 4 HA-units of WT-PR8 and mutant virus. Results are the average of three viral titrations and two HA assays per infectious virus titration
(TCID50 assay and HA titration experiments, mean + s.e.m). Statistical signiﬁcance was determined by unpaired t test. **P< 0.01; *P< 0.05. j Relative
abundance of genome segments in puriﬁed WT or mutant viruses. All segments were compared to segment 1 (PB2) vRNA and normalized to the average
of WT-PR8 values using the 2-ddCt method22. Bars represent the mean of 3–6 independent virus preparations + s.e.m. and statistical signiﬁcance was
determined by one-way ANOVA with a multiple comparisons correction (Kruskal–Wallis test). *P< 0.05. k C57BL/6J mice were inoculated with 103
TCID50 in 30 µL. Lungs were collected 48 hpi, homogenized, and titered. Each dot is a single mouse and the line is the median. Dotted line in k represents
the limit of detection and statistical signiﬁcance was determined by one-way ANOVA with a multiple comparisons correction (Kruskal–Wallis test).
(***P< 0.005, *P< 0.05)
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precipitated. Molarity of libraries was determined by qPCR (NEBNext, New
England Biosciences) and size by Bioanalyzer (Agilent). Illumina sequencing on the
HiSeq 2500 instrument (1 × 50 bp reads) was performed by the Genome Tech-
nology Access Center at Washington University in St. Louis.
Next-generation sequencing. All NGS data were analyzed on the Washington
University in Saint Louis School of Medicine’s McDonnell Genome Institute (MGI)
cluster using publically available analysis programs (FastX toolkit, Bowtie, and
SAMtools) and in-house scripts21. PAR-CLIP and RNA-seq data were generated
from four independent experiments. For PAR-CLIP and RNA-seq libraries we used















































































NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-02886-w ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:465 |DOI: 10.1038/s41467-018-02886-w |www.nature.com/naturecommunications 9
aligned them to the viral genome. Strandedness was determined post-alignment
and all subsequent analysis was performed on negative-sense viral genomic RNA
(vRNA). For reads that mapped to the viral RNAs, we normalized the number of
reads per nucleotide to the total number of reads per genome segment to yield a
normalized coverage ratio for both PAR-CLIP and RNA-seq libraries. We then
compared the normalized coverage for each preparation at nucleotide resolution
using an unpaired t test with False Discovery Rate (FDR) correction
(Benjamini–Hochberg)36. vRNA nucleotides with a FDR minima Q< 0.01 and
fold-change> 3 were identiﬁed and these regions were extended to the ﬁnal
nucleotide of each regionm, where Q ≤ 0.1. These areas represent low-NP or high-
NP-binding regions of interest (ROI). ROI ≥ 18 nt were subjected to RNA structure
analysis with mFold, RNAfold, and vsFold5 to determine computationally the
theoretical minimal free energy (ΔG) of each region as well as the potential sec-
ondary or tertiary RNA structure formation37,38. Nucleotide composition of ROIs
was determined by calculating the percent of A, G, C, or U in each region and
comparing them to the percent of each nucleotide in the IAV genome. PAR-CLIP
data sets were compared to RNA-seq data sets at each nucleotide position on a per-
segment basis and positions using unpaired t test with FDR correction as above
with a threshold of Q = 0.05. Sites of statistically enriched transition in PAR-CLIP
data sets were tabulated and the sequence distance between these positions was
calculated. Transition events with a step-size of 1, i.e. sequential nucleotides both
with high transition rate, and were excluded from analysis because they likely
represent single NP–RNA interactions of adjacent 4-SU nucleotides in vRNA.
Transition rate for four PAR-CLIP libraries were averaged prior to distance
calculation.
Generation of IAV containing altered RNA structures. Mutant selection was
performed after analysis of open reading frames to assess potential nucleotide
degeneracy while retaining coding sequence. Subsequently, we selected ﬁve
underrepresented ROIs in four segments (1, 2, 5, and 8) for functional assessment
of manipulating predicted RNA structures on viral replication. We also identiﬁed
four regions in segment 5, amenable to extensive silent mutagenesis that were
either highly bound or represented at the same frequency in PAR-CLIP and RNA-
seq data sets. We introduced between 2 and 7 synonymous mutations simulta-
neously in silico to the identiﬁed regions and reassessed structural stability or
pseudoknot formation using the same structure prediction programs. We selected
variant codon combinations that would disrupt or maintain the predicted vRNA
structure but not change the encoded amino acid, alter codon usage, or disrupt
alternative reading frames or splicing events. Once predicted destabilizing muta-
tions were identiﬁed, mutant viruses were generated. Mutations were introduced
into pHW2000 bidirectional plasmids by inverse PCR with primers (see Supple-
mentary Table 2) including selected mutations and unique ligation sites. PCR
products were gel extracted and digested with either BsmbI (New England Biolabs,
(NEB)) or AarI (Thermo Fisher Scientiﬁc) restriction enzymes and DpnI (NEB) to
remove residual parent plasmid. Digested PCR products were PCR puriﬁed and
ligated using Instant Sticky End Ligase (NEB). Ligation products were transformed
into E. coli, plated on selective LB Agar. Colonies were selected and grown over-
night in LB broth and selective antibiotics. All plasmids were grown in 200 ml LB
Broth prior to preparation by Qiagen HiSpeed Endotoxin-Free MaxiPrep and
veriﬁed by Sanger Sequencing (Genewiz).
Inﬂuenza A virus focus-forming assay. Six-well plates of MDCK cells were plated
and inoculated with 1 ml of 10-fold serially diluted virus stock for 1 h in M0.1B.
After 1 h, the inoculum was removed, and replaced with an overlay of 1% Low
Melting Point Agarose in MEM supplemented with 1 μg ml−1 TPCK-Trypsin.
Seventy-two hours post infection cells were ﬁxed in 5% formaldehyde, permeabi-
lized with 0.1% saponin in HBSS, and stained for NP protein with 1 µg ml−1
biotinylated anti-NP (mAB8258b, Millipore). Foci were visualized by addition of
HRP-conjugated streptavidin and TruBlue streptavidin substrate and imaged on a
Biospot reader (Cellular Technology Limited). Individual foci were counted and
area was calculated using the Analyze Particles extension within Fiji39. The area of
the foci formed by mutant viruses was normalized to the average of WT-PR8 foci
per experiment. A minimum of 60 foci was analyzed per virus.
Confocal microscopy. We infected 293T cells in the presence or absence (mock) of
4-SU with WT-PR8 (MOI of 1) for 16 h. Brieﬂy, 293T cells were seeded on glass
coverslips coated with poly-D lysine overnight. Cells were infected with WT-PR8
for 16 h then ﬁxed with 4% methanol-free PFA in PBS (pH 7.4), washed with PBS,
permeabilized with saponin, then NP staining was performed using anti-NP MAb
HB65 (1 µg ml−1) and goat-anti-mouse Alexa-488 (Invitrogen). Nuclei were
counterstained with DAPI. Coverslips were mounted to slides with ProLong®
Diamond Antifade Mountant (Molecular Probes). To determine if viral protein
production was impacted by synonymous mutations, we utilized confocal micro-
scopy to visualize the distribution of NP during infection as a marker of viral
protein production and a proxy for trafﬁcking of vRNPs. MDCK cells were infected
with WT-PR8 and indicated mutant viruses (MOI of 0.2) for 8 h, then ﬁxed and
permeabilized as before. NP staining was performed as above using anti-IAV-NP
MAb HB65 and Goat-anti-Mouse Alexa-488 (Invitrogen). Slides were imaged with
Zeiss LSM 880 Confocal Laser Scanning Microscopy with Airyscan and analyzed
with Zeiss Zen Black Software performed within the Molecular Microbiology
Imaging Facility at Washington University in Saint Louis.
Inﬂuenza A virus reporter assay. To assess the impact of silent mutations on
polymerase complex activity, pHW2000 plasmids encoding WT or mutant PB2,
PB1, PA, and NP were utilized in a dual-luciferase reporter assay as previously
described35. A vRNA-like ﬁreﬂy luciferase reporter plasmid and a Renilla luciferase
expression plasmid also were included. Brieﬂy, 293T cells were seeded into 24-well
plates and transfected with equal amounts of all six plasmids (500 ng DNA total) in
Opti-MEM containing TransIT-LT1 (Mirus). Cells were maintained at 37 °C for
the duration of the experiment. Forty-eight hours later, cells were lysed for analysis
of luciferase activities (Promega). Each combination of polymerase proteins (set of
plasmids) was examined in duplicate. The relative light units (RLU) of ﬁreﬂy
luciferase activity were normalized to the RLU for Renilla luciferase activity within
the same sample to account for differences in transfection efﬁciency between wells
and experiments. The activity of each plasmid set containing a mutant segment was
normalized to the activity of WT-PR8.
Flow cytometry. To determine the amount of NP generated at a ﬁxed time during
infection, we infected 2 × 105 MDCK cells (MOI of 0.2). Eight hours post-infection,
cells were collected and ﬁxed. Intracellular staining of IAV antigen was performed
as above using an anti-IAV NP primary antibody (HB65) (1 µg ml−1) and an
Alexa-488-conjugate goat-anti-mouse secondary antibody (Invitrogen). The mean
ﬂuorescence intensity (MFI) of NP+ cells was plotted and calculated from two
experiments performed in duplicate. Co-expression of NP and M in MDCK cells
was determined 16 hpi with an MOI of 5 and 0.05. Infected cells were ﬁxed and
stained as above with the additional staining step of utilizing mouse-anti-M pri-
mary antibody (M2-1C6) (2 µg ml−1) and goat-anti-mouse Alexa-647 secondary. A
second intracellular staining step utilizing biotinylated mouse-anti-NP
(mAb8258b) (1 µg ml−1) and Alexa-488 conjugated streptavidin was then per-
formed. The frequency of co-expression was calculated by determining the number
of cells expressing NP or M as well as those expressing both. The percentage of
infected cells co-expressing NP and M was calculated by dividing co-expressing
cells by all cells expressing one or more viral protein as previously described23.
Analysis of viral proteins was determined using a ﬂow cytometer and FlowJo
software (Tree Star).
Multi-step replication of inﬂuenza A virus. MDCK cells (2 × 105) were seeded in
24-well plates and inoculated the next day with 200 TCID50 of IAV. Cells were
washed once with PBS before addition of inoculum in M0.1B and incubated for 1 h
at 37 °C. Subsequently, the cells were washed twice with PBS and 1 ml of M0.1B
supplemented with 1 μg ml−1 TPCK-Trypsin was added to each well. Culture
Fig. 5 vRNA regions required for PR8 replication are required for replication of contemporary avian and human IAV. a Phylogenetic analysis of segment 5.
WT-PR8, WT-H7N3, or WT-pH1N1 IAV are indicated by corresponding, labeled arrows. Phylogenies were created from randomly sampled full-length
segment 5 sequences downloaded from NCBI IVR. Alignment performed in MEGA (version 7) using MUSCLE. Phylogenetic trees created using the
Maximum Parsimony method included in MEGA. Phylogenies were visualized in FigTree and manually annotated. Green shading represents segment
sequences derived from avian viruses; red represents human viruses; and blue represents swine viruses. b Phylogenetic analysis of segment 2 performed as
in a. c Relative focus area of WT-H7N3 and mutant viruses + s.e.m. The results are the average of 3 independent experiments and >60 foci per virus.
Statistical signiﬁcance was determined by one-way ANOVA with multiple comparisons correction (Kruskal–Wallis test). ****P< 0.001. d Viral titer
(TCID50 ml−1) of 4 HA-units of WT-H7N3 and mutant virus. Results are the average of three viral titrations and two HA assays per infectious virus titration
(TCID50 assay and HA titration experiments, mean + s.e.m.). Statistical signiﬁcance was determined by unpaired t test. ****P< 0.001. e Relative focus area
of WT-pH1N1 and mutant viruses + s.e.m. The results are the average of 3 independent experiments and >60 foci per virus. Statistical signiﬁcance was
determined by one-way ANOVA with multiple comparison corrections (Kruskal–Wallis test). ****P< 0.001. f Viral titer (TCID50 ml−1) of 4 HA-units of WT
and mutant virus. Results are the average of three viral titrations and two HA assays per infectious virus titration (TCID50 assay and HA titration
experiments, mean + s.e.m.). Statistical signiﬁcance was determined by unpaired t test. **** P< 0.001
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supernatants were collected at 24 and 48 hpi and the amount of infectious virus was
quantiﬁed by titration on MDCK cells.
Titration of inﬂuenza A virus (TCID50). Conﬂuent monolayers of MDCK cells
were grown overnight in 96-well tissue culture plates. The next day, the cells were
washed with PBS and inoculated with 10-fold serial dilutions of culture supernatant
or lung homogenate for 1 h in M0.1B at 37 °C. After 1 h, the inoculum was
removed and replaced with M0.1B supplemented with 1 μg ml−1 TPCK-Trypsin
and incubated for 72 h. Presence of virus was determined by hemagglutination
assay using 0.5% turkey red blood cells. TCID50 was determined by the
Reed–Muench method40.
Infection of mice with inﬂuenza viruses. Male C57BL/6 J mice (5–6 weeks of age)
were bred in-house in a barrier facility at Washington University School of
Medicine, St. Louis, MO or purchased from Jackson Laboratories. Mice received
food and water ad libitum and all experiments were conducted in accordance with
rules of the Institutional Animal Care and Use Committee. Mice were anesthetized
with isoﬂurane in an airﬂow chamber and then inoculated intranasally with 30 μL
of sterile PBS containing 1000 TCID50 of WT-PR8 or the indicated mutant virus.
Forty-eight hours post-infection, lungs were collected and homogenized in 1 ml
M0.1B, cleared by centrifugation at 1200 × g for 5 min, then stored in aliquots at
−80 °C. Viral titers from lung homogenates were determined by TCID50 assay.
Segment abundance RT-qPCR. MDCK cell derived stocks of WT-PR8 or mutant
viruses were clariﬁed by centrifugation at 1200 × g for 5 min, passed through a
0.22 µM ﬁlter, and pelleted on 30% sucrose cushion by ultracentrifugation (Beck-
man SW32ti swinging bucket rotor, 27 K RPM, 4 °C for 90 min). Pelleted virus
particles were directly resuspended in 350 μl TRK lysis buffer, and RNA puriﬁed
immediately and eluted in 30 μl DEPC H2O (Total RNA Kit I, Omega). cDNA was
synthesized from 5 µl of RNA with SSIII Reverse transcriptase (Invitrogen) and a
vRNA speciﬁc primer22. Total cDNA was diluted 1:10,000 and used to quantify
each of the 8 genome segments by SYBR Green qPCR (PowerUpTM SYBR® Green
Master Mix) with primer pairs previously published22. Relative abundance of each
genome segment was calculated as before, except with normalization to Segment 1
or 7 depending on the virus assessed.
RNA thermal denaturation experiments. The RNA oligomers corresponding to
PB1497–561, PB1497–561:A, and PB1497–561:B (Supplementary Table 2) were synthe-
sized commercially (Integrated DNA Technologies). RNA was diluted in buffer
(100 mM NaCl and 50 mM KCl) to a ﬁnal concentration of 10 µM, incubated at
95 °C for 5 min and ﬂash cooled on ice to induce folding. Unfolding of RNA
secondary structure was monitored by CD spectroscopy at 210 and 260 nm on a
Chirascan CD spectrometer (Applied Photophysics)41. RNA was heated from 5 to
95 °C at a rate of 1 °C/min and CD readings collected every 2 °C. A linear, least-
squares program was used to ﬁt the transition region of thermal melting curves. By
deﬁnition, the melting temperature of nucleic acid is the temperature at which 50%
of all nucleic acid becomes single-stranded for a single cooperative transition24.
The ellipticity at which half of the RNA is denatured was calculated using the
equation shown below and modiﬁed from (42):
Fd ¼ θn θobsð Þ= θn θdð Þ
where, Fd is the fraction of denatured nucleic acid, θn the minimum ellipticity at
210 nm or the maximum ellipticity at 260 nm, θd the maximum ellipticity at
210 nm or the minimum ellipticity at 260 nm, and θobs the observed ellipticity at
Fd. The ellipticity, θobs, when Fd = 0.5 was calculated and used to calculate Tm
from the linear ﬁt of the transition region. For comparisons between different RNA
samples, the ﬁrst derivative of the ellipticity, θobs, the change in molar ellipticity as
a function of temperature (dθ/dT), was calculated and plotted.
Statistical analysis. All statistical analyses were performed using GraphPad Prism
7.0. For comparison of PAR-CLIP and RNA-seq data sets, we used multiple
unpaired t tests with the Benjamini–Hochberg correction to identify areas in which
these sequencing preparations were statistically different from each other (Q< 0.1
and Q< 0.01). Transition-distance was determined using FDR (Q< 0.05). For
analysis of the focus-forming assay, luciferase assay, and lung viral titers, we used
one-way ANOVA with multiple comparison corrections (Kruskal–Wallis test).
TCID50 per HA-unit was analyzed using an unpaired t test.
Data availability. The unprocessed PAR-CLIP and RNA-seq ﬁles have been
uploaded to the NCBI Sequence Read Archive (SRA, SUB3042681). All other data
supporting the ﬁndings of this study are available within the article and its Sup-
plementary Information ﬁles, or are available from the authors upon request.
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